Trial Profile
Effects of Combined Treatment With Arsenic Trioxide and Itraconazole in Patients With Refractory Metastatic Basal Cell Carcinoma
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 28 Jan 2016
Price :
$35
*
At a glance
- Drugs Arsenic trioxide (Primary) ; Itraconazole (Primary)
- Indications Basal cell cancer
- Focus Therapeutic Use
- 28 Jan 2016 New trial record
- 13 Jan 2016 Results published in the JAMA Dermatology